InTandem Capital Partners, a healthcare services focused private equity firm, closed a supplemental private equity investment fund, InTandem Capital Opportunities Fund, at the hard cap of $225 million of limited partner commitments. The fund, which was significantly oversubscribed, will focus on providing expansion capital to existing portfolio companies and additional capital for future platform investments from InTandem Capital Partners Fund II, a vintage June 2019 fund that closed with $250 million in limited partner commitments. Read more.
Related Posts
Health Systems Notch Big Wins with Their IT Investments
Many forward-thinking hospitals and health systems are finding significant clinical, financial and operational ROI for their efforts.
September 5, 2023
US Regulators Urged to Block Amazon’s ‘Terrifying’ Purchase of One Medical
Privacy, antitrust, and other advocates sounded the alarm over Amazon's purchase of boutique healthcare company One Medical, a move that one group said "opens a terrifying new frontier in surveillance of Americans by private corporations."
July 22, 2022
HCA, CHS Execs ‘Hopeful’ Deferred Care will Trickle Back to Hospitals in 2022
CHS and HCA Healthcare pointed to first-quarter high acuity volumes, such as surgeries, that were roughly on par or above 2019 numbers.
May 16, 2022
Managing Oncology Practice Revenue in the Face of Rising Healthcare Costs and Regulatory Burden
VMG Health experts explore the typical reimbursement concerns for oncology practices, including managing the revenue cycle, proper Electronic Health Record (EHR) management, and policy concerns related to value-based care trends.
May 18, 2023